Last Updated: June 9, 2026

Suppliers and packagers for TUXARIN ER


✉ Email this page to a colleague

« Back to Dashboard


TUXARIN ER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323 NDA Mainpointe Pharmaceuticals 71269-040-10 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71269-040-10) 2018-10-15
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323 NDA Mainpointe Pharmaceuticals 71269-040-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71269-040-30) 2018-10-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TUXARIN ER

Last updated: June 5, 2026

Tuxarin ER Drug Suppliers: Who Manufactures and Supplies the Brand, API, and Dosage Forms?

No complete, source-backed answer is possible for “tuxarin ER” supplier coverage (brand manufacturer, API suppliers, and finished-dose manufacturers) because the underlying product identity and corresponding regulatory listings are not specified and cannot be validated from the information provided.

What is Tuxarin ER and who supplies it commercially?

Featured-snippet answer: Not available from the provided inputs.

Which active ingredient is “Tuxarin ER”?

Featured-snippet answer: Not available from the provided inputs.

Is Tuxarin ER an ER tablet, capsule, or suspension?

Featured-snippet answer: Not available from the provided inputs.

What suppliers provide the API for Tuxarin ER?

Featured-snippet answer: Not available from the provided inputs.

What contract manufacturers supply Tuxarin ER finished dosage forms?

Featured-snippet answer: Not available from the provided inputs.

Which sites make the ER formulation?

Featured-snippet answer: Not available from the provided inputs.

What is the Orange Book status of Tuxarin ER and how does that affect supplier mapping?

Featured-snippet answer: Not available from the provided inputs.

Is Tuxarin ER listed as an NDA, ANDA, or both?

Featured-snippet answer: Not available from the provided inputs.

How can you identify Tuxarin ER suppliers from FDA labels and inspection records?

Featured-snippet answer: Not available from the provided inputs.

What label fields list manufacturers and packagers?

Featured-snippet answer: Not available from the provided inputs.

Which FDA data sources typically confirm manufacturing responsibility?

Featured-snippet answer: Not available from the provided inputs.

Which companies are likely the suppliers if Tuxarin ER is a common active ingredient?

Featured-snippet answer: Not available from the provided inputs.

What supplier risks exist for Tuxarin ER (single-site, sole-source, or API constraints)?

Featured-snippet answer: Not available from the provided inputs.

Key Takeaways

  • No validated supplier roster (brand, API, contract manufacturer, or packager) can be produced for “tuxarin ER” from the information provided.
  • Supplier mapping for a specific ER drug requires the exact regulated product identity (active ingredient, strength, dosage form, and application number) to extract manufacturer and facility responsibilities from FDA and label data.

FAQs

  1. How do I find the finished-dose manufacturer for an ER tablet from the FDA label?
  2. Where do I locate the API manufacturer or site details for an NDA product?
  3. How do I use FDA inspection databases to map contract manufacturing for ER products?
  4. What label language indicates the packager vs. the manufacturer for prescription drugs?
  5. How does Orange Book listing correlate with the set of supplier facilities?

References

No sources are included because no verifiable citations can be produced from the provided input.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.